CO 019: SERUM LEVELS OF INFLAMMATORY MARKERS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION DURING A 6 MONTH FOLLOW UP

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S9, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 019: SERUM LEVELS OF INFLAMMATORY MARKERS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION DURING A 6 MONTH FOLLOW UP Brizuela NY, Ricarte Bratti JP, Vergottini JC, Ponce LN and Menara A. Cátedra Farmacología General. Facultad de … Continue reading CO 019: SERUM LEVELS OF INFLAMMATORY MARKERS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION DURING A 6 MONTH FOLLOW UP

J Pharm Pharmacogn Res 2(Suppl. 1): S9, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 019: SERUM LEVELS OF INFLAMMATORY MARKERS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION DURING A 6 MONTH FOLLOW UP

Brizuela NY, Ricarte Bratti JP, Vergottini JC, Ponce LN and Menara A.

Cátedra Farmacología General. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba. Santa Rosa 1085. (5000), Córdoba. Argentina. E-mail: nildabrizuela@gmail.com, nilda@fcm.unc.edu.ar
Abstract

Introduction: The inflammation plays a fundamental role in pathogenesis and complication of the atherosclerosis. Cytokines and adhesion molecules are key components of these events that contribute to the development of an atherosclerotic plaque. Their determination of plasma levels provides an excellent reflection of the underlying inflammatory process, since it is positively correlated with other markers such as pro-inflammatory cytokines. The cytokine Tumor necrosis factor alpha (TNF-α), the interleukin-6 (IL-6) and vascular adhesion molecule-1 (VCAM-1) are indicators of basal inflammation. This study reports on the follow-up of 27 patients, aged 42–82 years with confirmed acute myocardial infarction (AMI group) and a matched control group of 10 patients without coronary artery disease (control group).

Material and methods: Blood samples for determination of inflammatory markers were taken on the 3rd day and after 6 months. Concentrations of cytokines and adhesion molecules were measured using commercial Immunoassay (ELISA) kits (Amersham Sciences).

Results: The serum level of VCAM-1 in the AMI group was significantly higher than in control groups (P<0.01). In the acute phase of myocardial infarction (MI) the levels of TNF-α and IL-6 were higher than in the control group (P<0.01). Six months later the levels of TNFα, IL-6 and ICAM-1 normalized (P<0.001).

Conclusions: The present study showed that in the acute phase of AMI increased activation of pro inflammatory markers. In the course of healing within 6 months after the infarction the inflammatory reaction disappears. It is necessary to carry out further studies to clarify the role of adhesion molecules in acute coronary syndrome. Future studies of the prediction of recurrent vascular events after AMI should concentrate on clinical variables and different blood inflammatory markers.

Alendronate and platelet-rich plasma in sheep anterior cruciate ligament
J. Pharm. Pharmacogn. Res., vol. 12, no. 3, pp. 526-538, May-Jun 2024. DOI: https://doi.org/10.56499/jppres23.1845_12.3.526 Original Article Effect of alendronate and platelet-rich plasma in tendon-bones integration in sheep anterior cruciate ligament surgery [Efecto del alendronato y del plasma rico en plaquetas en la integración tendón-hueso en la cirugía del ligamento cruzado anterior ovino] Tangkas Sibarani1*, Bambang … Continue reading Alendronate and platelet-rich plasma in sheep anterior cruciate ligament
Brassicaceae selenium complexes versus SARS-COV-2 MAP4 and spike protein
J. Pharm. Pharmacogn. Res., vol. 12, no. 3, pp. 514-525, May-Jun 2024. DOI: https://doi.org/10.56499/jppres23.1739_12.3.514 Original Article Antiviral potential of selenium complexes from Brassicaceae by inhibiting protein bond between MAP4 and the spike of SARS-CoV-2 [Potencial antiviral de complejos de selenio de Brassicaceae mediante la inhibición de la unión proteica entre MAP4 y la espiga de … Continue reading Brassicaceae selenium complexes versus SARS-COV-2 MAP4 and spike protein
Andrographis paniculata and cardiovascular diseases
J. Pharm. Pharmacogn. Res., vol. 12, no. 3, pp. 487-513, May-Jun 2024. DOI: https://doi.org/10.56499/jppres23.1841_12.3.487 Review Andrographis paniculata: A potential supplementary therapy for cardiovascular diseases - A systematic review of its effects and molecular actions [Andrographis paniculata: Una terapia suplementaria potencial para las enfermedades cardiovasculares - Una revisión sistemática de sus efectos y acciones moleculares] Oluebube … Continue reading Andrographis paniculata and cardiovascular diseases

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio